ES476857A1 - Prostaglandin compositions - Google Patents

Prostaglandin compositions

Info

Publication number
ES476857A1
ES476857A1 ES476857A ES476857A ES476857A1 ES 476857 A1 ES476857 A1 ES 476857A1 ES 476857 A ES476857 A ES 476857A ES 476857 A ES476857 A ES 476857A ES 476857 A1 ES476857 A1 ES 476857A1
Authority
ES
Spain
Prior art keywords
prostaglandin
prostaglandin compositions
compositions
triglyceride
composition comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476857A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES476857A1 publication Critical patent/ES476857A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A stabilized prostaglandin composition comprises a prostaglandin and a hydrogenated starch hydrolysate and/or a non-ionic ester obtainable from a triglyceride and a polyalkylene polyol.
ES476857A 1978-01-17 1979-01-15 Prostaglandin compositions Expired ES476857A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46378 1978-01-17

Publications (1)

Publication Number Publication Date
ES476857A1 true ES476857A1 (en) 1979-05-16

Family

ID=4187587

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476857A Expired ES476857A1 (en) 1978-01-17 1979-01-15 Prostaglandin compositions

Country Status (20)

Country Link
JP (1) JPS54110313A (en)
AR (1) AR218518A1 (en)
AU (1) AU4337979A (en)
BE (1) BE873481A (en)
DD (1) DD141260A5 (en)
DE (1) DE2900428A1 (en)
DK (1) DK7679A (en)
ES (1) ES476857A1 (en)
FI (1) FI790043A (en)
FR (1) FR2414336A1 (en)
GB (1) GB2012168A (en)
GR (1) GR72910B (en)
IL (1) IL56435A0 (en)
IT (1) IT7947665A0 (en)
NL (1) NL7900255A (en)
NO (1) NO790059L (en)
NZ (1) NZ189380A (en)
PT (1) PT69073A (en)
SE (1) SE7900124L (en)
ZA (1) ZA79199B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3024676A (en) * 1958-11-28 1962-03-13 Sack Gmbh Maschf Hydraulic presses
US4211793A (en) * 1979-03-19 1980-07-08 American Cyanamid Company Triethyl citrate solutions of PGE-type compounds
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
CH651756A5 (en) * 1982-02-05 1985-10-15 Sandoz Ag PHARMACEUTICAL IN THE FORM OF A SUSPENSION CONTAINING THIORIDAZINE.
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
JPS60116628A (en) * 1983-11-29 1985-06-24 Teijin Ltd Composition of pharmaceutical preparation of 7- thiaprostaglandin e1
JPS60169430A (en) * 1984-02-14 1985-09-02 Teijin Ltd Composition for prostaglandin preparation
JPS6191136A (en) * 1984-10-09 1986-05-09 Teijin Ltd Composition for prostaglandin preparation
JPS61289034A (en) * 1985-06-17 1986-12-19 Teijin Ltd Fatty emulsion of prostaglandin i2
JPH04342530A (en) * 1991-04-26 1992-11-30 Teijin Ltd 7-fluoroprostacyclin fatty emulsion
WO2009026434A1 (en) * 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations

Also Published As

Publication number Publication date
NL7900255A (en) 1979-07-19
DE2900428A1 (en) 1979-07-19
IL56435A0 (en) 1979-03-12
AU4337979A (en) 1979-07-26
NO790059L (en) 1979-07-18
FI790043A (en) 1979-07-18
FR2414336B1 (en) 1981-07-31
ZA79199B (en) 1980-08-27
JPS54110313A (en) 1979-08-29
BE873481A (en) 1979-07-16
DK7679A (en) 1979-07-18
PT69073A (en) 1979-02-01
AR218518A1 (en) 1980-06-13
NZ189380A (en) 1981-01-23
DD141260A5 (en) 1980-04-23
GB2012168A (en) 1979-07-25
FR2414336A1 (en) 1979-08-10
IT7947665A0 (en) 1979-01-17
GR72910B (en) 1984-01-04
SE7900124L (en) 1979-07-18

Similar Documents

Publication Publication Date Title
AU520728B2 (en) Surfactant compositions
AU528892B2 (en) Polymer-polyol compositions
AU5383979A (en) Surfactant composition
AU519747B2 (en) Curable organopolysiloxane compositions
ZA791554B (en) Low irritating detergent compositions
AU508727B2 (en) Nandrolone 17 beta ester compositions
AU4682779A (en) Deodorizing composition for ash trays
ES476857A1 (en) Prostaglandin compositions
AU4731979A (en) Turbofan thrust vectoring
AU521250B2 (en) Curable organopolysiloxane compositions
AU523002B2 (en) Coal spray composition
AU530814B2 (en) Lubricant compositions containing dispersant additives
AU527406B2 (en) Peroxide-based bleach compositions
AU518723B2 (en) Curable acrylate ester compositions
AU4799179A (en) Curable compositions
AU523719B2 (en) Coating compositions
AU554024B2 (en) Glycerol esters as additives
AU529093B2 (en) Anaerobic compositions
AU532328B2 (en) Lubricating composition having self releasing properties
AU526347B2 (en) Polyarylene ester compositions
AU4837079A (en) Lubricant composition
AU534147B2 (en) Polyester-polyarylene ester compositions
AU525249B2 (en) Oil compositions
JPS5515470A (en) Pgi2 composition stabilized with surfactant
JPS5524149A (en) Cosmetic